---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-23-000071"
form_type: "8-K/A"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:29:50.029569+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints Schwab and Grayson to board; Grayson gets $350k bonus and large performance RSUs

## Summary
- Paul Grayson appointed director with a $350,000 sign-on bonus.
- 18.1M performance RSUs vest on market cap milestones: $125M, $250M, $400M, or $500M+ exit.
- Additional 43.4M performance RSUs subject to stockholder approval of plan amendment.
- Andrew Schwab appointed to board and compensation committee; standard non-employee director compensation.
- 7.4M stock options granted to non-employee directors; up to 17.6M more pending plan amendment.

## SEC filing metadata
- accession: 0001516551-23-000071
- form_type: 8-K/A
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000071/0001516551-23-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000071/skye-20230815.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-23-000071
- JSON: https://secwatch.observer/filing/0001516551-23-000071.json
- Plain text: https://secwatch.observer/filing/0001516551-23-000071.txt

## Key facts
- Executive change
  Andrew Schwab was appointed as Director at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: Andrew Schwab and Paul Grayson were appointed to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000071/0001516551-23-000071-index.htm
- Executive change
  Paul Grayson was appointed as Director at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: Andrew Schwab and Paul Grayson were appointed to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000071/0001516551-23-000071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.